Evaluation of IL-6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis.

( 13 ) This hypothesis is supported by the lack of significant differences in IL‐6 serum levels between patients with excellent results in PHES (5 to 0 points) and patients with slight but non‐pathologic impairment (0 to −4 points), while there was a highly significant increase in serum IL‐6 levels in patients with MHE and PHES results of −5 to −10 points compared to the group of patients with 0 to 4 points.

also in 132,142 other papers